Company news
Navamedic Asa (OSL:NAVA) news
Navamedic Asa news releases on 6ix. Latest, May 21, 2026: Navamedic launches Virono®- the first single-dose over-the-counter cold sore tablet
Press releases & updates
Navamedic launches Virono®- the first single-dose over-the-counter cold sore tablet
May 21, 2026
Major shareholder disclosure in Navamedic ASA
May 20, 2026
Navamedic ASA: Mandatory notification of trade
May 18, 2026
Navamedic ASA: Minutes of Annual General Meeting
April 23, 2026
Navamedic ASA: Invitation to presentation of first quarter 2026 results
April 20, 2026
Navamedic ASA: Recommendation of the nomination committee for the Annual General Meeting on 23 April 2026
April 15, 2026
Navamedic ASA: Notice of Annual General Meeting
March 31, 2026
Navamedic ASA: Invitation to presentation of fourth quarter 2025 results
February 9, 2026
Navamedic ASA: Minutes of Extraordinary General Meeting
January 7, 2026
Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026
December 12, 2025
Navamedic ASA: Appointment of CFO
December 8, 2025
Navamedic ASA: Resignation of CFO
November 28, 2025
Navamedic ASA: Double digit growth in the 3rd quarter, 2025
October 28, 2025
Navamedic ASA: Invitation to 2025 3rd quarter presentation
October 24, 2025
Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical
October 17, 2025
Navamedic : NOTIFICATION OF MAJOR HOLDINGS
October 15, 2025
Navamedic ASA - New share capital registered
October 13, 2025
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025
August 14, 2025
Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries
August 13, 2025
Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
July 15, 2025
Navamedic ASA - Minutes of Extraordinary General Meeting
July 14, 2025
Navamedic ASA: First approval of the medical device OraFID® as primary package for a pharmaceutical product
June 27, 2025
Navamedic ASA - Investor presentation regarding the acquisition of the business of dne pharma AS
June 24, 2025
Navamedic ASA expands into addiction treatment through the acquisition of the business of dne pharma and announces a partially underwritten rights issue
June 23, 2025
Navamedic ASA: Annual Report 2024
April 30, 2025
Navamedic ASA: Imdur® distribution agreement extended to 2032
April 29, 2025